Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Mar;15(3):903-9.
doi: 10.1128/iai.15.3.903-909.1977.

Contrasting effects of immunosuppression on Theiler's virus infection in mice

Contrasting effects of immunosuppression on Theiler's virus infection in mice

H L Lipton et al. Infect Immun. 1977 Mar.

Abstract

In the present study, cyclophosphamide and rabbit anti-mouse thymocyte serum were used to immunosuppress SJL/J mice infected with Theiler's mouse encephalomyelitis virus (TMEV) in order to delineate the potential mechanism(s) of virus-induced cellular injury in this infection. Whereas both immunosuppressive agents produced a significant increase in mortality, this treatment had differing effects on the pathological involvement of gray and white-matter structures in the central nervous system. The central nervous system of immunosuppressed TMEV-infected mice had increased microglial cell proliferation and neuronal necrosis, longer maintenance of high virus levels and spread of virus antigen to involve the neocortex and hippocampal complex. These observations indicate that TMEV causes a cytolotic infection of neurons and possibly other cells in gray matter. In contrast, immunosuppression produced a dramatic reduction in mononuclear inflammatory cells in the leptomeninges and spinal cord white matter of infected mice and prevented demyelination. Further, virus antigen was not detected in the leptomeninges and white matter of immunosuppressed and infected mice. These findings suggest that demyelination of TMEV infection is immune mediated.

PubMed Disclaimer

References

    1. Nature. 1975 Jun 12;255(5509):552-4 - PubMed
    1. Nature. 1975 Aug 21;256(5519):654-6 - PubMed
    1. Nature. 1976 May 13;261(5556):139-41 - PubMed
    1. Lab Invest. 1975 Dec;33(6):626-37 - PubMed
    1. J Exp Med. 1975 Feb 1;141(2):502-7 - PubMed

Publication types

LinkOut - more resources